Ablative fractional resurfacing in topical drug delivery: An update and outlook

Dermatologic Surgery

Volumn 39, Issue 6, 2013, Pages 839-848

  Bloom, Bradley S ^a   Brauer, Jeremy A ^b   Geronemus, Roy G ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LASER AND SKIN SURGERY CENTER OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; DEPIGMENTING AGENT; LATANOPROST; MINOXIDIL; PHOTOSENSITIZING AGENT; SCOPOLAMINE;

ABLATION THERAPY; ABLATIVE FRACTIONAL RESURFACING; CARBON DIOXIDE LASER; DERMIS; DIFFUSION COEFFICIENT; DRUG ABSORPTION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG RETENTION; DRUG TARGETING; ELECTROPORATION; EPIDERMIS; ERBIUM YAG LASER; FIRST PASS EFFECT; HUMAN; HYDROPHOBICITY; IONTOPHORESIS; LIPID SOLUBILITY; LIPOGENESIS; LIPOPHILICITY; MOLECULAR SIZE; MOTION SICKNESS; NONHUMAN; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SKIN PENETRATION; SKIN STRUCTURE; STRATUM CORNEUM; SUBCUTANEOUS TISSUE; TRANSDERMAL PATCH;

ABLATION TECHNIQUES; ADMINISTRATION, TOPICAL; DERMATOLOGIC SURGICAL PROCEDURES; DRUG DELIVERY SYSTEMS; HUMANS; LASER THERAPY;

EID: 84878764075     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/dsu.12111     Document Type: Review

References (78)

1. Bachhav YG, Summer S, Heinrich A, Bragagna T, et al. Effect of controlled laser microporation on drug transport kinetics into and across the skin. J Control Release 2010; 146: 31-6.
2. Michael R, Mark P, Sheree Elizabeth C,. Skin transport. In:, Walters KA, editor. Dermatological and transdermalformulations. New York: M. Dekker; 2002. pp. 97-215.
3. Potts RO, Francoeur ML,. The influence of stratum corneum morphology on water permeability. J Invest Dermatol 1991; 96: 495-9.
4. Elias PM, Menon GK,. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991; 24: 1-26.
5. Scheuplein RJ, Blank IH,. Permeability of the skin. Physiol Rev 1971; 51: 702-47.
6. Prausnitz MR, Elias PM, Franz TJ, Schmuth M, et al. Skin barrier and transdermal drug delivery. In:, Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology, 3rd edn. Philadelphia, PA: Elsevier Saunders; 2012. pp. 2065-74.
7. Kurihara-Bergstrom T, Good WR,. Skin development and permeability. J Control Release 1987; 6: 51-58.
8. Nemanic MK, Elias PM,. In situ precipitation: a novel cytochemical technique for visualization of permeability pathways in mammalian stratum corneum. J Histochem Cytochem 1980; 28: 573-8.
9. Rougier A, Dupuis D, Lotte C, Roguet R, et al. In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J Invest Dermatol 1983; 81: 275-8.
10. Haftek M, Teillon MH, Schmitt D,. Stratum corneum, corneodesmosomes and ex vivo percutaneous penetration. Microsc Res Tech 1998; 43: 242-9.
11. Menon GK, Elias PM,. Morphologic basis for a pore-pathway in mammalian stratum corneum. Skin Pharmacol 1997; 10: 235-46.
12. Scheuplein RJ,. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 1967; 48: 79-88.
13. Braverman IM,. The cutaneous microcirculation. J Invest Dermatol Symposium proceedings 2000; 5: 3-9.
14. Teichmann A, Jacobi U, Ossadnik M, Richter H, et al. Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol 2005; 125: 264-9.
15. Blume-Peytavi U, Vogt A,. Human hair follicle: reservoir function and selective targeting. Br J Dermatol 2011; 165 (Suppl 2): 13-7.
16. Hou YW, Chan MH, Hsu HR, Liu BR, et al. Transdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptides. Exp Dermatol 2007; 16: 999-1006.
17. Franz TJ,. Kinetics of cutaneous drug penetration. Int J Dermatol 1983; 22: 499-505.
18. Prausnitz MR, Mitragotri S, Langer R,. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 2004; 3: 115-24.
19. Merwe E, Ackermann C,. Physical changes in hydrated skin. Int J Cosmet Sci 1987; 9: 237-47.
20. Mikulowska A,. Reactive changes in human epidermis following simple occlusion with water. Contact dermatitis 1992; 26: 224-7.
21. Williams AC, Barry BW,. Penetration enhancers. Adv Drug Deliv Rev 2004; 56: 603-18.
22. Karande P, Jain A, Ergun K, Kispersky V, et al. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci USA 2005; 102: 4688-93.
23. Sinico C, Fadda AM,. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 2009; 6: 813-25.
24. Tsai JC, Guy RH, Thornfeldt CR, Gao WN, et al. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. J Pharm Sci 1996; 85: 643-8.
25. DeLouise LA,. Applications of nanotechnology in dermatology. J Invest Dermatol 2012; 132: 964-75.
26. Rothbard JB, Garlington S, Lin Q, Kirschberg T, et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med 2000; 6: 1253-7.
27. Kim YC, Ludovice PJ, Prausnitz MR,. Transdermal delivery enhanced by magainin pore-forming peptide. J Control Release 2007; 122: 375-83.
28. Spruit D, Malten KE,. The regeneration of the water vapour loss of heavily damaged skin. Dermatologica 1966; 132: 115-23.
29. Banga AK, Bose S, Ghosh TK,. Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm 1999; 179: 1-19.
30. Monteiro-Riviere NA, Inman AO, Riviere JE,. Identification of the pathway of iontophoretic drug delivery: light and ultrastructural studies using mercuric chloride in pigs. Pharm Res 1994; 11: 251-6.
31. Green PG,. Iontophoretic delivery of peptide drugs. J Control Release 1996; 41: 33-48.
32. Mayes S, Ferrone M,. Fentanyl HCl patient-controlled iontophoretic transdermal system for the management of acute postoperative pain. Ann Pharmacother 2006; 40: 2178-86.
33. Prausnitz MR, Bose VG, Langer R, Weaver JC,. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 1993; 90: 10504-8.
34. Wu J, Chappelow J, Yang J, Weimann L,. Defects generated in human stratum corneum specimens by ultrasound. Ultrasound Med Biol 1998; 24: 705-10.
35. Bommannan D, Menon GK, Okuyama H, Elias PM, et al. Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res 1992; 9: 1043-7.
36. Ogura M, Paliwal S, Mitragotri S,. Low-frequency sonophoresis: current status and future prospects. Adv Drug Deliv Rev 2008; 60: 1218-23.
37. Van der Maaden K, Jiskoot W, Bouwstra J,. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 2012; 161: 645-55.
38. Haedersdal M, Sakamoto FH, Farinelli WA, Doukas AG, et al. Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med 2010; 42: 113-22.
39. Lee WR, Shen SC, Al-Suwayeh SA, Yang HH, et al. Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules. J Control Release 2011; 153: 240-8.
40. Lee WR, Shen SC, Lai HH, Hu CH, et al. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs. J Control Release 2001; 75: 155-66.
41. Manstein D, Herron GS, Sink RK, Tanner H, et al. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34: 426-38.
42. Alexiades-Armenakas MR, Dover JS, Arndt KA,. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol 2008; 58: 719-37; quiz 38-40.
43. Brightman LA, Brauer JA, Anolik R, Weiss E, et al. Ablative and fractional ablative lasers. Dermatol Clin 2009; 27: 479-89, vi-vii.
44. Haedersdal M, Katsnelson J, Sakamoto FH, Farinelli WA, et al. Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Lasers Surg Med 2011; 43: 804-13.
45. Tannous Z,. Fractional resurfacing. Clin Dermatol 2007; 25: 480-6.
46. Berlin AL, Hussain M, Phelps R, Goldberg DJ,. A prospective study of fractional scanned nonsequential carbon dioxide laser resurfacing: a clinical and histopathologic evaluation. Dermatol Surg 2009; 35: 222-8.
47. Chapas AM, Brightman L, Sukal S, Hale E, et al. Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing. Lasers Surg Med 2008; 40: 381-6.
48. Ciocon DH, Engelman DE, Hussain M, Goldberg DJ,. A split-face comparison of two ablative fractional carbon dioxide lasers for the treatment of photodamaged facial skin. Dermatol Surg 2011; 37: 784-90.
49. Dierickx CC, Khatri KA, Tannous ZS, Childs JJ, et al. Micro-fractional ablative skin resurfacing with two novel erbium laser systems. Lasers Surg Med 2008; 40: 113-23.
50. Haedersdal M,. Fractional ablative CO(2) laser resurfacing improves a thermal burn scar. J Eur Acad Dermatol Venereol 2009; 23: 1340-1.
51. Hantash BM, Bedi VP, Kapadia B, Rahman Z, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med 2007; 39: 96-107.
52. Lapidoth M, Yagima Odo ME, Odo LM,. Novel use of erbium:YAG (2,940-nm) laser for fractional ablative photothermolysis in the treatment of photodamaged facial skin: a pilot study. Dermatol Surg 2008; 34: 1048-53.
53. Waibel J, Beer K,. Ablative fractional laser resurfacing for the treatment of a third-degree burn. J Drugs Dermatol 2009; 8: 294-7.
54. Brightman LA, Brauer JA, Anolik R, Weiss ET, et al. Reduction of thickened flap using fractional carbon dioxide laser. Lasers Surg Med 2011; 43: 873-4.
55. Lee WR, Shen SC, Pai MH, Yang HH, et al. Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser. J Control Release 2010; 145: 124-33.
56. Beltraminelli H, Dietrich N, Hunziker T,. Fractional transepidermal delivery: a histological analysis. Dermatology 2011; 223: 321-4.
57. Na JI, Choi JW, Choi HR, Jeong JB, et al. Rapid healing and reduced erythema after ablative fractional carbon dioxide laser resurfacing combined with the application of autologous platelet-rich plasma. Dermatol Surg 2011; 37: 463-8.
58. Hsiao CY, Huang CH, Hu S, Ko YS, et al. Fractional carbon dioxide laser treatment to enhance skin permeation of ascorbic acid 2-glucoside with minimal skin disruption. Dermatol Surg 2012; 38: 1284-93.
59. Yu J, Kalaria DR, Kalia YN,. Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies. J Control Release 2011; 156: 53-9.
60. Oni G, Brown SA, Kenkel JM,. Can fractional lasers enhance transdermal absorption of topical lidocaine in an in vivo animal model? Lasers Surg Med 2012; 44: 168-74.
61. Sakamoto F, Wanner M, Farinelli W, Doukas A, et al. Aminolevulinic acid photodynamic therapy (ALA-PDT) delivered after ablative fractional resurfacing in an animal model. Lasers Surg Med 2009; 41: Abstract 79.
62. Farkas JP, Richardson JA, Brown SA, Ticker B, et al. TUNEL assay to characterize acute histopathological injury following treatment with the active and deep FX fractional short-pulse CO2 devices. Aesthet Surg J 2010; 30: 603-13.
63. Farkas JP, Richardson JA, Burrus CF, Hoopman JE, et al. In vivo histopathologic comparison of the acute injury following treatment with five fractional ablative laser devices. Aesthet Surg J 2010; 30: 457-64.
64. Haak C, Bhayana B, Farinelli W, Anderson R, et al. Fractional CO2 laser assisted drug delivery is affected by laser density and molecular weight. Lasers Surg Med 2012; 44: 36-7.
65. Waibel J, Davis S, Badiavas E,. A pilot study of laser assisted delivery of allogeneic mesenchymal cutaneous stem cells resulting in functional chimeric mouse model. Lasers Surg Med 2012; 44: 37.
66. Fatemi A, Weiss MA, Weiss RA,. Short-term histologic effects of nonablative resurfacing: results with a dynamically cooled millisecond-domain 1320 nm Nd:YAG laser. Dermatol Surg 2002; 28: 172-6.
67. Alexiades-Armenakas MR, Geronemus RG,. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 2003; 139: 1313-20.
68. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007; 56: 125-43.
69. Marmur ES, Schmults CD, Goldberg DJ,. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 2004; 30: 264-71.
70. Morton CA, McKenna KE, Rhodes LE,. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008; 159: 1245-66.
71. Martin A, Tope WD, Grevelink JM, Starr JC, et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res 1995; 287: 665-74.
72. Sandberg C, Halldin CB, Ericson MB, Larko O, et al. Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo. Br J Dermatol 2008; 159: 1170-6.
73. Angell-Petersen E, Sorensen R, Warloe T, Soler AM, et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006; 126: 265-71.
74. Peng Q, Soler AM, Warloe T, Nesland JM, et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol, B 2001; 62: 140-5.
75. Rhodes LE, de Rie MA, Leifsdottir R, Yu RC, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007; 143: 1131-6.
76. Kineston D, Kwan JM, Uebelhoer NS, Shumaker PR,. Use of a fractional ablative 10.6-mum carbon dioxide laser in the treatment of a morphea-related contracture. Arch Dermatol 2011; 147: 1148-50.
77. Baron ED, Harris L, Redpath WS, Shapiro H, et al. Laser-assisted penetration of topical anesthetic in adults. Arch Dermatol 2003; 139: 1288-90.
78. Yun PL, Tachihara R, Anderson RR,. Efficacy of erbium:yttrium-aluminum- garnet laser-assisted delivery of topical anesthetic. J Am Acad Dermatol 2002; 47: 542-7.